`Q9998` Inj ustekinumab-aekn, 1 mg

Injection, ustekinumab-aekn (selarsdi), biosimilar, 1 mg

Medicare coverage: Carrier judgment
Status: active (July 2026 file)
MUE: max 520 units per day (practitioner), rationale: Prescribing Information